BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 28831766)

  • 1. NMR resonance assignments of the EVH1 domain of neurofibromin's recruitment factor Spred1.
    Führer S; Ahammer L; Ausserbichler A; Scheffzek K; Dunzendorfer-Matt T; Tollinger M
    Biomol NMR Assign; 2017 Oct; 11(2):305-308. PubMed ID: 28831766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction between a Domain of the Negative Regulator of the Ras-ERK Pathway, SPRED1 Protein, and the GTPase-activating Protein-related Domain of Neurofibromin Is Implicated in Legius Syndrome and Neurofibromatosis Type 1.
    Hirata Y; Brems H; Suzuki M; Kanamori M; Okada M; Morita R; Llano-Rivas I; Ose T; Messiaen L; Legius E; Yoshimura A
    J Biol Chem; 2016 Feb; 291(7):3124-34. PubMed ID: 26635368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The neurofibromin recruitment factor Spred1 binds to the GAP related domain without affecting Ras inactivation.
    Dunzendorfer-Matt T; Mercado EL; Maly K; McCormick F; Scheffzek K
    Proc Natl Acad Sci U S A; 2016 Jul; 113(27):7497-502. PubMed ID: 27313208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenic Mutations Associated with Legius Syndrome Modify the Spred1 Surface and Are Involved in Direct Binding to the Ras Inactivator Neurofibromin.
    Führer S; Tollinger M; Dunzendorfer-Matt T
    J Mol Biol; 2019 Sep; 431(19):3889-3899. PubMed ID: 31401120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural Insights into the SPRED1-Neurofibromin-KRAS Complex and Disruption of SPRED1-Neurofibromin Interaction by Oncogenic EGFR.
    Yan W; Markegard E; Dharmaiah S; Urisman A; Drew M; Esposito D; Scheffzek K; Nissley DV; McCormick F; Simanshu DK
    Cell Rep; 2020 Jul; 32(3):107909. PubMed ID: 32697994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A shared molecular mechanism underlies the human rasopathies Legius syndrome and Neurofibromatosis-1.
    Stowe IB; Mercado EL; Stowe TR; Bell EL; Oses-Prieto JA; Hernández H; Burlingame AL; McCormick F
    Genes Dev; 2012 Jul; 26(13):1421-6. PubMed ID: 22751498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Legius syndrome, an Update. Molecular pathology of mutations in SPRED1.
    Brems H; Legius E
    Keio J Med; 2013; 62(4):107-12. PubMed ID: 24334617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SPRED proteins provide a NF-ty link to Ras suppression.
    McClatchey AI; Cichowski K
    Genes Dev; 2012 Jul; 26(14):1515-9. PubMed ID: 22802525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SPRED1 Interferes with K-ras but Not H-ras Membrane Anchorage and Signaling.
    Siljamäki E; Abankwa D
    Mol Cell Biol; 2016 Oct; 36(20):2612-25. PubMed ID: 27503857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SPRED1, a RAS MAPK pathway inhibitor that causes Legius syndrome, is a tumour suppressor downregulated in paediatric acute myeloblastic leukaemia.
    Pasmant E; Gilbert-Dussardier B; Petit A; de Laval B; Luscan A; Gruber A; Lapillonne H; Deswarte C; Goussard P; Laurendeau I; Uzan B; Pflumio F; Brizard F; Vabres P; Naguibvena I; Fasola S; Millot F; Porteu F; Vidaud D; Landman-Parker J; Ballerini P
    Oncogene; 2015 Jan; 34(5):631-8. PubMed ID: 24469042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SPRED1 mutations (Legius syndrome): another clinically useful genotype for dissecting the neurofibromatosis type 1 phenotype.
    Spurlock G; Bennett E; Chuzhanova N; Thomas N; Jim HP; Side L; Davies S; Haan E; Kerr B; Huson SM; Upadhyaya M
    J Med Genet; 2009 Jul; 46(7):431-7. PubMed ID: 19443465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review and update of SPRED1 mutations causing Legius syndrome.
    Brems H; Pasmant E; Van Minkelen R; Wimmer K; Upadhyaya M; Legius E; Messiaen L
    Hum Mutat; 2012 Nov; 33(11):1538-46. PubMed ID: 22753041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and mutational spectrum of neurofibromatosis type 1-like syndrome.
    Messiaen L; Yao S; Brems H; Callens T; Sathienkijkanchai A; Denayer E; Spencer E; Arn P; Babovic-Vuksanovic D; Bay C; Bobele G; Cohen BH; Escobar L; Eunpu D; Grebe T; Greenstein R; Hachen R; Irons M; Kronn D; Lemire E; Leppig K; Lim C; McDonald M; Narayanan V; Pearn A; Pedersen R; Powell B; Shapiro LR; Skidmore D; Tegay D; Thiese H; Zackai EH; Vijzelaar R; Taniguchi K; Ayada T; Okamoto F; Yoshimura A; Parret A; Korf B; Legius E
    JAMA; 2009 Nov; 302(19):2111-8. PubMed ID: 19920235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-126 expression is decreased in cultured primary chicken hepatocytes and targets the sprouty-related EVH1 domain containing 1 mRNA.
    Wang XG; Shao F; Wang HJ; Yang L; Yu JF; Gong DQ; Gu ZL
    Poult Sci; 2013 Jul; 92(7):1888-96. PubMed ID: 23776277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Sprouty-related protein, Spred, inhibits cell motility, metastasis, and Rho-mediated actin reorganization.
    Miyoshi K; Wakioka T; Nishinakamura H; Kamio M; Yang L; Inoue M; Hasegawa M; Yonemitsu Y; Komiya S; Yoshimura A
    Oncogene; 2004 Jul; 23(33):5567-76. PubMed ID: 15184877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SPRED1 germline mutations caused a neurofibromatosis type 1 overlapping phenotype.
    Pasmant E; Sabbagh A; Hanna N; Masliah-Planchon J; Jolly E; Goussard P; Ballerini P; Cartault F; Barbarot S; Landman-Parker J; Soufir N; Parfait B; Vidaud M; Wolkenstein P; Vidaud D; France RN
    J Med Genet; 2009 Jul; 46(7):425-30. PubMed ID: 19366998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired instrumental learning in Spred1
    Borrie SC; Horner AE; Yoshimura A; Legius E; Kopanitsa MV; Brems H
    Genes Brain Behav; 2021 Jun; 20(5):e12727. PubMed ID: 33624414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MEK inhibition ameliorates social behavior phenotypes in a Spred1 knockout mouse model for RASopathy disorders.
    Borrie SC; Plasschaert E; Callaerts-Vegh Z; Yoshimura A; D'Hooge R; Elgersma Y; Kushner SA; Legius E; Brems H
    Mol Autism; 2021 Jul; 12(1):53. PubMed ID: 34311771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype.
    Brems H; Chmara M; Sahbatou M; Denayer E; Taniguchi K; Kato R; Somers R; Messiaen L; De Schepper S; Fryns JP; Cools J; Marynen P; Thomas G; Yoshimura A; Legius E
    Nat Genet; 2007 Sep; 39(9):1120-6. PubMed ID: 17704776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of the receptor FGFRL1 with the negative regulator Spred1.
    Zhuang L; Villiger P; Trueb B
    Cell Signal; 2011 Sep; 23(9):1496-504. PubMed ID: 21616146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.